The UAB MCRC is a multidisciplinary program uniquely positioned to promote research related to the causes, diagnoses, treatments and improved care of patients with arthritis and musculoskeletal diseases. The MCRC builds on the capabilities of the UAB Comprehensive Arthritis, Musculoskeletal, and Autoimmunity Center (CAMAC) and its thematic workgroups (Experimental Therapeutics &Biomarkers;Neurobehavioral Medicine;Epidemiology, Prevention, &Outcomes;Genetics and Functional Genomics;Immunology, Autoimmunity &Inflammation;Bone, Cartilage and Connective Tissue). An outstanding MCRC Methodology Core is comprised of experts in biostatistics (Redden, Howard, McGwin, Aslibekyan), data management (Westfall), statistical genetics and bioinformatics (Cui, Lefkowitz, Liu) and health services research (Kilgore). All have a proven record of collaborative clinical investigation in musculoskeletal diseases. This proposal includes 3 innovative projects: 1. Genetic Determinants of Cell Type-Specific Gene Expression in RA (Brown/Bridges);2. Facilitating Treat-to-Target Strategies Using Novel Health Technology with Decision Support (Curtis);3. Adaptive Immune Responses to Gut Microbiota in Juvenile &Adult Spondyloarthritis (Elson). Projects 1 and 3 focus on populations for which there is a paucity of clinical research: (African-Americans with RA and juvenile spondyloarthritis). All projects leverage and expand upon substantial existing resources, including ongoing cohorts. The Administrative Core coordinates MCRC activities, sets the strategic agenda, facilitates interactions and collaborations, promotes scientific development, and performs evaluation of MCRC programs. Four advisory groups have been established to assist the MCRC Director and Associate Director in maximizing the strengths of the MCRC's projects, as well as in identifying and correcting weaknesses: 1. Executive Committee;2. Internal Advisory Committee;3. External Advisory Committee;4. Data Safety Monitoring Committee. The Scientific Development Program, which promotes the introduction and development of new techniques and nurtures young and new faculty in arthritis and musculoskeletal disease research, ensures the continued energy and vitality of this MCRC.

Public Health Relevance

The UAB MCRC will support innovative research to: 1. Understand regulation of gene expression in immune cells of African-Americans with RA;2. Utilize electronic tools to help rheumatologists improve outcomes of RA patients;3. Understand the role of intestinal bacteria in children and adults with spondyloarthritis. MCRC programs will teach new research methods and encourage new investigators in rheumatic diseases.

National Institute of Health (NIH)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Comprehensive Center (P60)
Project #
Application #
Study Section
Special Emphasis Panel (ZAR1-KM (M1))
Program Officer
Wang, Yan Z
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Alabama Birmingham
Internal Medicine/Medicine
Schools of Medicine
United States
Zip Code
Hartman, Holly; Wang, Yuge; Schroeder Jr, Harry W et al. (2018) Absorbance summation: A novel approach for analyzing high-throughput ELISA data in the absence of a standard. PLoS One 13:e0198528
Stoll, Matthew L; Pierce, M Kathy; Watkins, Jordan A et al. (2018) Akkermansia muciniphila is permissive to arthritis in the K/BxN mouse model of arthritis. Genes Immun :
Curtis, Jeffrey R; Chen, Lang; Danila, Maria I et al. (2018) Routine Use of Quantitative Disease Activity Measurements among US Rheumatologists: Implications for Treat-to-target Management Strategies in Rheumatoid Arthritis. J Rheumatol 45:40-44
Stoll, Matthew L; Weiss, Pamela F; Weiss, Jennifer E et al. (2018) Age and fecal microbial strain-specific differences in patients with spondyloarthritis. Arthritis Res Ther 20:14
Curtis, Jeffrey R; Chen, Lang; Higginbotham, Phillip et al. (2017) Social media for arthritis-related comparative effectiveness and safety research and the impact of direct-to-consumer advertising. Arthritis Res Ther 19:48
Yun, Huifeng; Xie, Fenglong; Beyl, Randall N et al. (2017) Risk of Hypersensitivity to Biologic Agents Among Medicare Patients With Rheumatoid Arthritis. Arthritis Care Res (Hoboken) 69:1526-1534
Paulsen, Jesseca A; Ptacek, Travis S; Carter, Stephen J et al. (2017) Gut microbiota composition associated with alterations in cardiorespiratory fitness and psychosocial outcomes among breast cancer survivors. Support Care Cancer 25:1563-1570
Curtis, Jeffrey R; Chen, Lang; Greenberg, Jeffrey D et al. (2017) The clinical status and economic savings associated with remission among patients with rheumatoid arthritis: leveraging linked registry and claims data for synergistic insights. Pharmacoepidemiol Drug Saf 26:310-319
Yen, Po-Yin; Lara, Barbara; Lopetegui, Marcelo et al. (2016) Usability and Workflow Evaluation of ""RhEumAtic Disease activitY"" (READY). A Mobile Application for Rheumatology Patients and Providers. Appl Clin Inform 7:1007-1024
Stoll, Matthew L; Cron, Randy Q (2016) The microbiota in pediatric rheumatic disease: epiphenomenon or therapeutic target? Curr Opin Rheumatol 28:537-43

Showing the most recent 10 out of 29 publications